140 related articles for article (PubMed ID: 35027338)
21. Treatment Outcomes of Low-grade Lymphoma of the Orbit.
Holloway CL; Pickles T; Croteau NS; Wai ES
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):e298-e304. PubMed ID: 35210133
[TBL] [Abstract][Full Text] [Related]
22. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent.
Teckie S; Qi S; Lovie S; Navarrett S; Hsu M; Noy A; Portlock C; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):130-7. PubMed ID: 25863760
[TBL] [Abstract][Full Text] [Related]
24. Radiation Therapy Efficacy and Toxicity for Orbital and Ocular Adnexal Mucosa-Associated Lymphoid Tissue (OAMALT): A Single-Center, Retrospective Study of 32 Cases.
Xu L; Tang X; Jiang N; Zhang S; Cao Y; Sun X
Cancer Manag Res; 2021; 13():8017-8024. PubMed ID: 34707410
[TBL] [Abstract][Full Text] [Related]
25. Long-term treatment of localized gastric marginal zone B-cell mucosa associated lymphoid tissue lymphoma including incidence of metachronous gastric cancer.
Ono S; Kato M; Takagi K; Kodaira J; Kubota K; Matsuno Y; Komatsu Y; Asaka M
J Gastroenterol Hepatol; 2010 Apr; 25(4):804-9. PubMed ID: 20492338
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy.
Goda JS; Gospodarowicz M; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Tsang RW
Cancer; 2010 Aug; 116(16):3815-24. PubMed ID: 20564130
[TBL] [Abstract][Full Text] [Related]
27. Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of Vienna.
Kiesewetter B; Lamm W; Neuper O; Mayerhoefer ME; Simonitsch-Klupp I; Raderer M
Hematol Oncol; 2019 Oct; 37(4):345-351. PubMed ID: 31283840
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma.
Tran KH; Campbell BA; Fua T; MacManus M; Ryan G; Chesson B; Wirth A
Leuk Lymphoma; 2013 Mar; 54(3):491-6. PubMed ID: 23020137
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas.
Cerrato M; Orlandi E; Vella A; Bartoncini S; Iorio GC; Bongiovanni D; Capriotti F; Boccomini C; Vassallo F; Cavallin C; De Luca V; Giglioli FR; Ricardi U; Levis M
Br J Radiol; 2021 Jul; 94(1123):20210012. PubMed ID: 34111959
[TBL] [Abstract][Full Text] [Related]
30. Recurrence patterns of mucose-associated lymphoid tissue lymphoma after definitive radiation treatment: A single center experience.
Joo JH; Lee SW; Huh J; Suh C; Yoon DH; Ahn SD; Choi EK; Kim JH
Hematology; 2016 Oct; 21(9):542-8. PubMed ID: 27168138
[TBL] [Abstract][Full Text] [Related]
31. Results of Upfront Therapy for Marginal Zone Lymphoma.
Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
[TBL] [Abstract][Full Text] [Related]
32. Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit.
Ben Simon GJ; Cheung N; McKelvie P; Fox R; McNab AA
Ophthalmology; 2006 Jul; 113(7):1209-13. PubMed ID: 16647129
[TBL] [Abstract][Full Text] [Related]
33. Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients.
Bayraktar S; Bayraktar UD; Stefanovic A; Lossos IS
Br J Haematol; 2011 Jan; 152(1):72-80. PubMed ID: 21083656
[TBL] [Abstract][Full Text] [Related]
34. Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.
Ludmir EB; Milgrom SA; Pinnix CC; Gunther JR; Westin J; Fayad LE; Khoury JD; Medeiros LJ; Dabaja BS; Nastoupil LJ
Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):244-250. PubMed ID: 30686775
[TBL] [Abstract][Full Text] [Related]
35. A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG).
Isobe K; Kagami Y; Higuchi K; Kodaira T; Hasegawa M; Shikama N; Nakazawa M; Fukuda I; Nihei K; Ito K; Teshima T; Matsuno Y; Oguchi M;
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1181-6. PubMed ID: 17601683
[TBL] [Abstract][Full Text] [Related]
36. Radiation therapy for orbital lymphoma.
Zhou P; Ng AK; Silver B; Li S; Hua L; Mauch PM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):866-71. PubMed ID: 15925453
[TBL] [Abstract][Full Text] [Related]
37. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
38. The prognosis of patients with primary pulmonary mucosa-associated lymphoid tissue lymphoma: Treated with surgery or chemotherapy?
Ning Y; He H; Li Q; Zhao D; Xie D
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38400749
[TBL] [Abstract][Full Text] [Related]
39. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study.
Desai A; Joag MG; Lekakis L; Chapman JR; Vega F; Tibshirani R; Tse D; Markoe A; Lossos IS
Blood; 2017 Jan; 129(3):324-332. PubMed ID: 27789481
[TBL] [Abstract][Full Text] [Related]
40. Outcome analysis for stage IE and IIE thyroid lymphoma.
DiBiase SJ; Grigsby PW; Guo C; Lin HS; Wasserman TH
Am J Clin Oncol; 2004 Apr; 27(2):178-84. PubMed ID: 15057158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
